Cargando…
Eptinezumab for migraine
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
NPS MedicineWise
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218390/ https://www.ncbi.nlm.nih.gov/pubmed/35755991 http://dx.doi.org/10.18773/austprescr.2022.030 |
| _version_ | 1784731877252268032 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9218390 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | NPS MedicineWise |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92183902022-06-23 Eptinezumab for migraine Aust Prescr New Drugs NPS MedicineWise 2022-04-29 2022-06 /pmc/articles/PMC9218390/ /pubmed/35755991 http://dx.doi.org/10.18773/austprescr.2022.030 Text en (c) NPS MedicineWise https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
| spellingShingle | New Drugs Eptinezumab for migraine |
| title | Eptinezumab for migraine |
| title_full | Eptinezumab for migraine |
| title_fullStr | Eptinezumab for migraine |
| title_full_unstemmed | Eptinezumab for migraine |
| title_short | Eptinezumab for migraine |
| title_sort | eptinezumab for migraine |
| topic | New Drugs |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218390/ https://www.ncbi.nlm.nih.gov/pubmed/35755991 http://dx.doi.org/10.18773/austprescr.2022.030 |